GluN2A-containing NMDA Receptors Treatment

Depression has been linked to disruptions in excitation and inhibition within the prefrontal cortex, motivating the development of novel antidepressant strategies that restore cortical balance. GluN2A-containing NMDA receptors play a critical role in synaptic signaling, with receptor gating regulated by interactions between GluN1 and GluN2A subunits. GNE-8324 is a preclinical, GluN2A-selective positive allosteric modulator that binds at the GluN1–GluN2A interface and enhances receptor gating, particularly within inhibitory interneurons. In this project, the GluN2A-containing NMDA receptor and GNE-8324 were modeled using low-fidelity prototyping and high-resolution 3D printing techniques. The resulting physical models visualize ligand binding, conformational changes, and receptor activation states. These representations clarify the mechanism of action of GNE-8324 and its stabilizing effect on the ligand-binding domain. This work demonstrates how physical modeling can enhance understanding of NMDA receptor modulation and highlights the therapeutic potential of GluN2A-selective PAMs in depression treatment.